Letters to the Editor

Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphoma

Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Radiation-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Stem cell transplant and Cellular therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Haematologica Early view Mar 19, 2026 https://doi.org/10.3324/haematol.2025.300402